Societies

Mark your calendars for our upcoming virtual Grand Rounds to explore the use of Precision Medicine through the TAPUR Study – ASCO

Photo taken from ASCO/LinkedIn

Apr 11, 2024, 17:43

Mark your calendars for our upcoming virtual Grand Rounds to explore the use of Precision Medicine through the TAPUR Study – ASCO

American Society of Clinical Oncology (ASCO) shared a post LinkedIn:

“Mark your calendars for our upcoming virtual Grand Rounds to explore the use of Precision Medicine through the TAPUR Study. The TAPUR Study is an ongoing Clinical Trial conducted by ASCO that examines the potential of using targeted therapies outside of their approved use to benefit patients with later-stage cancer, leading to increased options for personalised therapies.
When: Monday, May 6, at 2:00 PM ET
Where: Online
Who: Open to all members of the oncology community

Featured speakers include:

Richard Schilsky, TAPUR Study Principal Investigator.
Jens Rueter, Medical Director of the Maine Cancer Genomics Initiative.
Janet Freeman-Daily, Lung cancer patient and advocate; President of The ROS1ders.”

Additional information.
Source: ASCO/LinkedIn

American Society of Clinical Oncology ASCO cancer Janet Freeman-Daily Jens Rueter Lung cancer OncoDaily Oncology patient Precision Medicine Richard Schilsky TAPUR The ROS1ders

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage